Background
It has recently been suggested that glucose variability may be an independent risk factor for vascular complications of diabetes [
1,
2]. Recently, glucose oscillations, like those experienced daily by diabetic patients, have been demonstrated to be more dangerous in vitro than constant high glucose; this is true for several cell types, including endothelial cells [
3‐
7]. A higher generation of free radicals during glucose oscillations has been hypothesized as a causal factor for this phenomenon [
3‐
7].
It has been shown that endogenous antioxidant enzymes protect cells against the toxic effect of reactive oxygen species (ROS) and are an essential defence system against oxidative injury [
8]. Under normal physiological conditions, ROS production is balanced by an efficient system of antioxidants: such molecules are capable of neutralizing them and thereby preventing oxidant damage. Superoxide anion, a highly reactive molecule, can be converted into less reactive hydrogen peroxide (H
2O
2) by the cytosolic Cu/Zn-superoxide dismutase (SOD-1), and by the mitochondrial located Mn-superoxide dismutase (SOD-2), whereas glutathione peroxidase-1 (GPx-1) and catalase (CAT) play a role in the further enzymatic catabolism of ROS [
8].
The aim of this study was to compare the response in human endothelial cells of this antioxidant system during glucose oscillation to that which takes place during chronic stable glucose exposure.
A new class of small non-coding RNAs, termed microRNAs (miRNAs or miRs), is emerging as new regulators of metabolism during development and disease [
9]. miRNAs are endogenous ~23 nt long, non-coding RNA molecules that play important gene regulatory roles in cells by pairing to the un-translated region (3′-UTR) of mRNAs of protein-coding genes in order to direct their post-transcriptional repression [
10]. miRNA recognises complementary miRNA recognition elements (MRE) throughout mRNA sequences, including 3′- and 5′-UTRs. The dysregulation of miRNA expression can affect the expression of hundreds mRNAs and proteins. miRNAs are found in different genomic regions: introns of protein-coding genes; exons and introns of non-coding genes and even the 3′-untranslated region (3′-UTR) of protein-coding genes [
12].
Multiple studies have demonstrated that a large number of miRNAs is under the control of various metabolic stimuli, including glucose [
11]. Although many miRNAs have already been identified, their roles in the regulation of key genes and signaling pathways associated with glucose stimuli still remain poorly understood. Recently, microRNA-185 (miR-185) has been related to altered expression of selenoproteins, including altered GPx-1 [
13], but its direct binding did have not yet been reported. Therefore, in this work, we sought to evaluate the possible modulation carried out by miR-185 during glucose oscillations on GPx-1 expression.
Methods
Materials and cell cultures
Primary pooled human umbilical vein endothelial cells (HUVECs) and growth factors were purchased from Lonza (Lonza Bioresearch LBS, Basel, Switzerland). Cells were maintained for 3 weeks in endothelial basal medium, supplemented with low fetal bovine serum (2 %), hydrocortisone (1 µg/mL), basal fibroblastic growth factor (5 ng/mL), epidermal growth factor (5 ng/mL), heparin (0.75 units/mL) and gentamicin/amphotericin (GA-1000, 0.1 %) in a humidified incubator with 5 % carbon dioxide added.
Experimental design and glucose exposures
2 × 105 HUVECs/well were seeded in 6-well plates (Corning, NY, USA) and exposed for 7 days to three different glucose concentrations: normal glucose (NG; 5 mmol/l), oscillating glucose (OG; 5/25 mmol/l) and high glucose (HG; 25 mmol/l). OG condition was obtained changing glucose concentration (from 5 to 25 mmol/l) every day. Experimental control was performed incubating the cells with mannitol at the same concentration of glucose.
Determination of 8-hydroxy-2′-deoxyguanosine (8-OHdG)
8-OH-dG, a marker of oxidative stress, was determined in the HUVECs using Bioxytech 8-OHdG-EIA Kit (OXIS Health Products, Portland, OR, USA).
RNA extraction and Real-time PCR (q-PCR) analysis
Total RNA was extracted using an RNA purification kit (NorgenBiotek, Thorold, ON, Canada). One microgram of total RNA was reverse transcribed using the SuperScript III reverse transcriptase and random hexamers (Invitrogen, Life Technologies, Grand Island, NY, USA). q-PCR was performed using the ABI 7900 HT thermo-cycler (Applied Biosystems, Life Technologies, Grand Island, NY, USA), in a reaction buffer using Taqman Gene expression Master Mix, with pre-optimized primers and probes obtained from Applied Biosystems, and using SYBR green ready mix (SYBR
® Premix Ex Taq™ II, Taqara, Japan). The list of primers used is reported in Table
1. All
q-
PCR were normalized to actin-beta, as a housekeeping gene.
GPx-1 | 5′-CCCAGTCGGTGTATGCCTTC-3′ 5′-AGCATGAAGTTGGGCTCGAA-3′ | NM_000581.2 |
SOD-2 | 5′-GGCCTACGTGAACAACCTGA-3′ 5′-CAGGACGTTATCTTGCTGGG-3′ | NM_001024465 |
SOD-1 | Hs00533490_m1 | NM_000454.4 |
CAT | Hs00156308_m1 | NM_001752.3 |
ACTB | Hs99999903_m1 | NM_001101.3 |
Endogenous expression, mimic and inhibition of miR-185
miR-185 expression was examined with the TaqMan MicroRNA Assay Kit (Applied Biosystems, Life Technologies, Grand Island, NY, USA). MultiScribe Reverse Transcriptase was used for RT-PCR, and TaqMan primers for hsa-miR-185 (assay ID 002271) were used to monitor miR-185 expression. RNU44/48 or SNORD-44/48 (assay ID 001094/ID 001006) was used as endogenous miRNA controls (all purchased from Applied Biosystems). has-miR-185-5p mirVana® miRNA mimic (MC12486), Anti-miR™miRNA-185 inhibitor (AM12486), an antisense miR-185, and scrambled Anti-miR™miRNA inhibitor negative control (AM17010) was purchased from Ambion (Foster City, CA, USA). Transfections of miRNA-185 inhibitors were performed at least three times in triplicate using INTERFERin® transfection reagent according to the manufacturer’s protocol (POLYPLUS-transfection, NY, USA).
Target predictions of miRNAs
The target gene predictions of human miRNAs have been gathered from a publicly available database for miRNAs target predictions (TargetScan 5.2,
http://www.targetscan.org, for poorly conserved sites [
14]). Sequence for miRNA was obtained from the miRNA database, miRBase (Faculty of Life Sciences, University of Manchester). RNA hybrid tool [
15] was used to predict the resulting secondary structure formed by interacting mRNA and miRNA and calculate ΔG minimum free energy. RNA hybrid is available at
https://bibiserv.techfak.unibiekefeld.de/rnahybrid.
HUVEC co-transfection for functional assay
HUVEC 5 × 104 cells passage 4 (p4) were transiently co-transfected with 3′-UTR-GPx-1 expression vector firefly luciferase reporter assay (Origene, MD, USA), containing the entire 217 bp GPx-1 3′-UTR together with miRNA-185 mimic sequence, using jetPRIME co-transfection reagent following manufacturer’s instructions (POLYPLUS). As controls, cells were transfected with empty vector (pMIR) alone, and with pMIR with miRNA-185 mimic sequence. Cells were processed for lysis and collected 72 h after co-transfection and luciferase activity of total cell lysates measured using an established luciferase reporter assay kit (Dual Luciferase Reporter System, Promega, USA). Luciferase values were normalized calculating RLU/μg protein.
Western immunoblots
Whole cell lysates were prepared using RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA) containing a protease and phosphatase inhibitor cocktail. Protein contents were determined using the Bradford Reagent (Sigma-Aldrich, St. Louis, MO, USA). Whole cell lysates and chromatin-bound nuclear extracts were subjected to 4–20 % Tris–glycine gradient (SDS-PAGE) gels (Lonza Bioresearch LBS, Basel, Switzerland) in reducing conditions and blotted onto a polyvilynidene fluoride membrane. After blocking with 5 % non-fat dry milk in 20 mM Tris–HCl (pH 7.5), 135 mM NaCl, and 0.1 % Tween-20, blots were incubated with polyclonal antibodies against phospho-histone2AX (γ-H2AX) obtained from Cell Signaling (Beverly, MA, USA), washed with 20 mM Tris–HCl (pH 7.5), 135 mM NaCl, and 0.1 % Tween-20, and incubated with a horseradish peroxidase-conjugated secondary antibody. Proteins were detected using the ECL system (Pierce Chemical, Rockford, IL, USA), according to the manufacturer’s instructions and revealed using a CCD camera (ImageQuantLAS4000, GE Healthcare, UK). Antibodies against SOD-1, CAT, GPx-1 (Cell Signaling, Beverly, MA, USA), and SOD-2 (Santa Cruz Biotechnology, CA, USA) were blotted in the same conditions. β-Actin (Sigma-Aldrich, St. Louis, MO, USA) was used as loaded control, whereas histone-H3 (Abcam) was used for a chromatin-bound nuclear extract loaded control. Protein content quantification was performed using computer-assisted densitometry (
http://www.imagej.nih.gov, ImageJ, NIH, Bethesda, MD, USA).
Chromatin-bound nuclear extracts were prepared using Subcellular Protein Fractionation Kit for Cultured Cells (Pierce Chemical, Rockford, IL, USA) according to the manufacturer’s description. Thus, HUVECs (2 × 106) cells were fractionated, equal amounts of chromatin-bound nuclear extracts (30 µg) were separated in 4–20 % Tris–glycine gradient gels (Lonza Bioresearch LBS, Basel, Switzerland), and then run on SDS-PAGE in reducing conditions.
Measurement of GPx activity
HUVECs (1 × 106) were subjected to lysis and sonication (2 × 30 s) on ice. Supernatants were collected and assayed for protein content using Bradford assay. GPx protein activity was measured by GPx activity colorimetric assay kit (Biovision, Milpitas, CA, USA) according to the manufacturer’s instructions and normalized by protein content.
Statistical analysis
Results are expressed as mean ± SEM. Statistical analysis was performed using GraphPrism5.0
® (
http://www.graphpad.com). Differences between groups were carried out by one-way ANOVA, followed by the Tukey’s post hoc test. Significant differences were assumed at p < 0.05. Three different experiments were performed in triplicate to ensure reproducibility.
Discussion
In vitro studies report that OG is more dangerous than HG for several kinds of cells [
3‐
7]. Moreover, these studies consistently prove that this is due to an increase in oxidative stress generation in OG compared to HG [
3‐
7].
The intracellular antioxidant defense system plays a key role in protecting cells during the generation of oxidative stress: generally under these conditions there is an increase in key intracellular antioxidant enzymes, such as SODs, CAT and GPx, aiming to protect cells [
8]. This response is also active in oxidative stress generated by HG with the only exception of SOD-2, which does not increase [
18].
In this study, for the first time, we report that during OG the response of an antioxidant enzyme, GPx-1, is defective compared to what happens in HG. The absence of an increase of GPx-1 in OG, compared to HG, in our opinion, can convincingly explain the more damaging effects of OG on cells as compared to HG. When GPx-1 does not increase, clearly the oxidative stress produced in cells by glucose is more dangerous to the cells. This hypothesis is further supported by our data regarding the markers of oxidative stress, which are more elevated in OG than in HG.
miRNAs are known as important regulators for target mRNA stability and translation. Recently, it has been shown their influence on many cellular functions including glucose metabolism [
19]. Important roles for these miRNAs have emerged in the control of metabolic pathways, as suggested by studies implicating miRNAs in the regulation of fat metabolism, adipocyte differentiation, energy homeostasis, and glucose-stimulated insulin secretion [
20]. Many studies have identified specific miRNAs expression profiles of diabetes and described the critical roles of miRNAs in insulin secretion [
21,
22], pancreatic development and function [
22] and diabetic cardiovascular complications [
23]. However, the role of several miRNAs, such as miR-21, -146a [
24,
25] and let7A [
26] as regulators in inflammation and oxidative stresses has been reported.
We have found that OG increases miR-185 expression, a phenomenon that convincingly leads to a decreased expression of its target GPx-1. MIR185 cytogenetic location was found by genomic sequence analysis; Wang et al. (2013) [
27] mapped the gene within the first intron of the C22ORF25 gene (also known as Transport and golgi organization 2 homolog,
Tango2) on chromosome 22q11.21 in sense orientation. Deletion of this region it has been associated with Di George syndrome, and consequently loss of miR-185 contributes to the cardiac defects in the syndrome [
28]. In mouse was detected highest relative miR-185 expression in liver and has been related to lipid metabolism [
27]. Recent experimentally validated targets for miR-185, such as Camk2d, Ncx1, and Nfatc3 have been related to cardiac diseases [
29,
30]. Moreover, IL-10Rα was found a direct target of miR-185, demonstrating a further role in inflammation [
31].
Our study suggests a key role of miR-185 in the dangerous effects of OG. If confirmed in vivo, the evidence of a defective GPx-1 response to OG could help explain the mounting evidence linking glucose variability with diabetic complications [
1,
2]. In recent years it has emerged the hypothesis that glucose variability can contribute to the development of complications in diabetes. Recently, high blood glucose variability has been defined as an independent determinant of increased lipid and decreased fibrous contents with larger coronary plaque burden [
32] and may impact the formation of lipid-rich plaques and thinning of fibrous cap in CAD patients on lipid-lowering therapy [
33]. Moreover, one-year visit-to-visit glucose variability predicted development of end stage renal disease in T2DM patients [
34] and was independently associated with the presence of cardiovascular autonomic neuropathy in patients with inadequately controlled T2DM [
35]. In our previous study we found that in oscillating and high glucose, total endoglin, its soluble form (sENG), KLF-6 and HIF-1 α were significantly increased [
36], and glucose variability reduction via continuous subcutaneous insulin infusion in T1DM increases circulating EPCs levels, suggesting a novel mechanism of vascular damage by oscillating glucose [
37].
Consistently, the activity of the antioxidant enzymes CAT, SODs and of GPx has been described as defective in diabetics with complications [
38,
39], and an association in vivo has been found between reduced GPx activity and increased risk of cardiovascular complications in diabetes [
40].
Glutathione plays a central role in antioxidant defense [
41]. Reduced glutathione detoxifies ROS, such as H
2O
2, and lipid peroxides, directly or in a GPx-catalyzed mechanism [
42]. GPx-1 is an abundant cytoplasmic enzyme specifically involved in the response to peroxyl-radicals and plays an important role in intracellular detoxification. It has been found to be more effective than CAT in removing intracellular peroxides under many different physiological conditions [
42,
43]. Moreover, GPx-1 catalyzes the conversion of H
2O
2 or organic hydro-peroxides into water, or its corresponding alcohols, using glutathione as a substrate [
44], and protects against oxidative and nitrosative stress in blood vessels [
45]. H
2O
2 forms the toxic oxygen species hydroxyl radical, which is highly reactive and causes lipid peroxidation, and hydroxide anion, which promotes alkaline tissue damage, a process that is offset in part by CAT and GPx-1-dependent reduction to H
2O. A deficiency in GPx-1 would then lead to an increase in ROS. Thus, a defective GPx-1 response in OG can expose the vasculature to potentially important damage.
Authors’ contributions
LLS contributed to: conception and design of the study, acquisition, analysis and interpretation of data wrote manuscript and approved the manuscript submission. MC, VDN, GP, RT, ARB and SG contributed to: acquisition and analysis, interpretation of data, revising the manuscript and approved the manuscript submission. AC contributed to: conception and design of the study, analysis and interpretation of data wrote manuscript and approved the manuscript submission. All authors read and approved the final manuscript.